Arun Kanakkanthara

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Breast Cancer Risk

Acinetobacter Baumannii

Top Venues

Cancer research

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas L Ekstrom, Nicholas M Pathoulas, Amelia M Huehls, Arun Kanakkanthara, Larry M Karnitz
VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases. Molecular cancer therapeutics 20 (9) (2021)
Arun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, Valentina Zanfagnin, Amelia M Huehls, Rebecca L Kelly, Husheng Ding, Melissa C Larson, George Vasmatzis, Ann L Oberg, Scott H Kaufmann, Aaron S Mansfield, S John Weroha, Larry M Karnitz
Repurposing ceritinib induces DNA damage and enhances PARP inhibitor responses in high-grade serous ovarian carcinoma. Cancer research (2021)
Arun Kanakkanthara, Kiran Kurmi, Thomas L Ekstrom, Xiaonan Hou, Emma R Purfeerst, Ethan P Heinzen, Cristina Correia, Catherine J Huntoon, Daniel O'Brien, Andrea E Wahner Hendrickson, Sean C Dowdy, Hu Li, Ann L Oberg, Taro Hitosugi, Scott H Kaufmann, S John Weroha, Larry M Karnitz
BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents. Cancer research 79 (23) (2019)
Arun Kanakkanthara, Catherine J Huntoon, Xiaonan Hou, Minzhi Zhang, Ethan P Heinzen, Daniel R O'Brien, Ann L Oberg, S John Weroha, Scott H Kaufmann, Larry M Karnitz
ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer. Nature communications 10 (1) (2019)